Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma

This publication has 46 references indexed in Scilit:

• Hepatocellular carcinoma
  Published by Elsevier ,2003
• The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
  Annals of Internal Medicine, 2003
• Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma
  Molecular Carcinogenesis, 2003
• Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?
  The Oncologist, 2002
• Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
  The Oncologist, 2002
• International trends and patterns of primary liver cancer
  International Journal of Cancer, 2001
• Trends in Survival of Patients With Hepatocellular Carcinoma Between 1977 and 1996 in the United States
  Hepatology, 2001
• Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma
  Liver International, 1997
• Quantitative Relationship Between Transforming Growth Factor-Alpha and Hepatic Focal Phenotype and Progression in Female Mouse Liver
  Toxicologic Pathology, 1997
• Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcinogenesis in rat
  Cancer Letters, 1997